Invasive lobular carcinoma: clinicopathological features and subtypes

J Int Med Res. 2021 Jun;49(6):3000605211017039. doi: 10.1177/03000605211017039.

Abstract

Objective: To analyze the characteristics of invasive lobular carcinoma (ILC) compared with invasive ductal carcinoma (IDC) and to investigate the impact of histology on axillary lymph node (ALN) involvement in luminal A subtype tumors.

Methods: We retrospectively analyzed patients diagnosed with ILC or IDC from 2012 to 2016 who underwent surgery. Patients constituted 493 primary early breast cancer cases (82 ILC; 411 IDC).

Results: Compared with IDC, ILC tumors were significantly more likely to be grade 2, estrogen receptor- (ER) positive (+), have a lower proliferation rate (Ki67 <14%), and a higher pathological T stage (pT2-4). The luminal A subtype was significantly more common in ILC compared with IDC. In a multivariate regression model, grade 2, ER+, progesterone receptor-positive, pT2, and pT3 were significantly associated with ILC. Additionally, with the luminal A subtype, ALN involvement (pathological node stage (pN)1-3) was significantly more frequent with ILC versus IDC.

Conclusions: Our data suggest that grade 2, positive hormone receptor status, and higher pathological T stage are associated with ILC. With the luminal A subtype, ALN involvement was more frequent with ILC versus IDC.

Keywords: Invasive breast cancer; axillary lymph node involvement; breast cancer subtypes; invasive ductal carcinoma; invasive lobular carcinoma; pathological stage.

MeSH terms

  • Breast Neoplasms*
  • Carcinoma, Ductal, Breast* / surgery
  • Carcinoma, Lobular* / surgery
  • Female
  • Humans
  • Retrospective Studies